Correlation Engine 2.0
Clear Search sequence regions

Prostate cancer (PCa) is one of the most common solid cancers and one of the most important causes of morbidity and mortality worldwide in men. So far, several efforts have been devoted to identify prostate cancer biomarkers, which allow a discrimination between indolent and clinically significant diseases, however with scarce results. The prostate-specific antigen (PSA) still remains the marker of choice for PCa diagnosis, prognosis, and «active surveillance». Thus, a sensitive and specific independent indicator, easy to screen in blood or urine is still not available. This review will provide a new insight into the role of previous (i.e. PSA) and new biomarkers, to use separately or in combination for prostate cancer screening and early detection programs.


M Provenzano. New biomarkers in prostate cancer]. Praxis. 2012 Jan 18;101(2):115-21

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 22252593

View Full Text